Protalix Biotherapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PLX American 8731 https://protalix.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Protalix Biotherapeutics Inc

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript - Mar 15th, 2024 5:17 pm
PLX: Elfabrio Geographic Expansion - Mar 15th, 2024 9:45 am
Protalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023 - Mar 14th, 2024 12:11 pm
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results - Mar 14th, 2024 10:50 am
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 - Mar 7th, 2024 11:50 am
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference - Feb 23rd, 2024 11:50 am
Protalix BioTherapeutics Issues 2024 Letter to Stockholders - Dec 26th, 2023 11:50 am
Levicept Appoints Eliot Forster as CEO - Nov 30th, 2023 9:00 am
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript - Nov 7th, 2023 2:04 pm
PLX: More Regulatory Approvals - Nov 7th, 2023 9:25 am
Protalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Results - Nov 6th, 2023 1:04 pm
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results - Nov 6th, 2023 11:50 am
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023 - Oct 30th, 2023 10:50 am
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel - Oct 9th, 2023 10:50 am
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors - Sep 12th, 2023 10:50 am
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Sep 6th, 2023 10:50 am
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2023 Earnings Call Transcript - Aug 8th, 2023 1:14 pm
PLX: Second Quarter Results - Aug 8th, 2023 10:51 am
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results - Aug 7th, 2023 10:50 am
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference - Aug 1st, 2023 10:50 am